A deuterated drug is a small molecule medicinal product in which one or more of the hydrogen atoms contained in the drug molecule have been replaced by its heavier stable isotope deuterium. Because of the kinetic isotope effect, deuterium-containing drugs may have significantly lower rates of metabolism, and hence a longer half-life.
This report contains market size and forecasts of Deuterated Drugs in Global, including the following market information:
Global Deuterated Drugs Market Size 2024-2030, ($ millions)
The global Deuterated Drugs market is projected to reach US$ million by 2029.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Deuterated Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Deuterated Drugs Market, by Type, 2024-2030 ($ millions)
Global Deuterated Drugs Market Segment Percentages, by Type
Austedo
Zepsun
Others
Global Deuterated Drugs Market, by Application, 2024-2030 ($ millions)
Global Deuterated Drugs Market Segment Percentages, by Application
Huntington'S Disease (HD)
Tardive Dyskinesia (TD)
Cancer
Others
Global Deuterated Drugs Market, By Region and Country, 2024-2030 ($ Millions)
Global Deuterated Drugs Market Segment Percentages, by region and country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Teva
Suzhou Zelgen Biopharmaceuticals
Concert Pharmaceuticals
Vertex Pharmaceuticals
Hinova Pharma
Otsuka Pharmaceutical (Avanir)
Poxel SA (DeuteRx)
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Deuterated Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Deuterated Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Deuterated Drugs Overall Market Size
2.1 Global Deuterated Drugs Market Size: 2023 VS 2030
2.2 Global Deuterated Drugs Market Size, Prospects & Forecasts: 2023-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key Deuterated Drugs Players in Global Market
3.2 Global Companies Deuterated Drugs Product & Technology
4 Deuterated Drugs Companies Profiles
4.1 Teva
4.1.1 Teva Company Summary
4.1.2 Teva Business Overview
4.1.3 Teva Deuterated Drugs Product Offerings & Technology
4.1.4 Teva Deuterated Drugs R&D, and Plans
4.2 Suzhou Zelgen Biopharmaceuticals
4.2.1 Suzhou Zelgen Biopharmaceuticals Company Summary
4.2.2 Suzhou Zelgen Biopharmaceuticals Business Overview
4.2.3 Suzhou Zelgen Biopharmaceuticals Deuterated Drugs Product Offerings & Technology
4.2.4 Suzhou Zelgen Biopharmaceuticals Deuterated Drugs R&D, and Plans
4.3 Concert Pharmaceuticals
4.3.1 Concert Pharmaceuticals Company Summary
4.3.2 Concert Pharmaceuticals Business Overview
4.3.3 Concert Pharmaceuticals Deuterated Drugs Product Offerings & Technology
4.3.4 Concert Pharmaceuticals Deuterated Drugs R&D, and Plans
4.4 Vertex Pharmaceuticals
4.4.1 Vertex Pharmaceuticals Company Summary
4.4.2 Vertex Pharmaceuticals Business Overview
4.4.3 Vertex Pharmaceuticals Deuterated Drugs Product Offerings & Technology
4.4.4 Vertex Pharmaceuticals Deuterated Drugs R&D, and Plans
4.5 Hinova Pharma
4.5.1 Hinova Pharma Company Summary
4.5.2 Hinova Pharma Business Overview
4.5.3 Hinova Pharma Deuterated Drugs Product Offerings & Technology
4.5.4 Hinova Pharma Deuterated Drugs R&D, and Plans
4.6 Otsuka Pharmaceutical (Avanir)
4.6.1 Otsuka Pharmaceutical (Avanir) Company Summary
4.6.2 Otsuka Pharmaceutical (Avanir) Business Overview
4.6.3 Otsuka Pharmaceutical (Avanir) Deuterated Drugs Product Offerings & Technology
4.6.4 Otsuka Pharmaceutical (Avanir) Deuterated Drugs R&D, and Plans
4.7 Poxel SA (DeuteRx)
4.7.1 Poxel SA (DeuteRx) Company Summary
4.7.2 Poxel SA (DeuteRx) Business Overview
4.7.3 Poxel SA (DeuteRx) Deuterated Drugs Product Offerings & Technology
4.7.4 Poxel SA (DeuteRx) Deuterated Drugs R&D, and Plans
5 Sights by Region
5.1 By Region - Global Deuterated Drugs Market Size, 2024 & 2030
5.2 By Region - Global Deuterated Drugs Revenue, (2024-2030)
5.3 United States
5.3.1 Key Players of Deuterated Drugs in United States
5.3.2 United States Deuterated Drugs Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of Deuterated Drugs in Europe
5.4.2 Europe Deuterated Drugs Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of Deuterated Drugs in China
5.5.2 China Deuterated Drugs Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global Deuterated Drugs Market Size Markets, 2024 & 2030
6.2 Austedo
6.3 Zepsun
6.4 Others
7 Sights by Application
7.1 By Application - Global Deuterated Drugs Market Size, 2024 & 2030
7.2 Huntington'S Disease (HD)
7.3 Tardive Dyskinesia (TD)
7.4 Cancer
7.5 Others
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Deuterated Drugs Market Opportunities & Trends in Global Market
Table 2. Deuterated Drugs Market Drivers in Global Market
Table 3. Deuterated Drugs Market Restraints in Global Market
Table 4. Key Players of Deuterated Drugs in Global Market
Table 5. Global Companies Deuterated Drugs Product & Technology
Table 6. Teva Company Summary
Table 7. Teva Deuterated Drugs Product Offerings
Table 8. Suzhou Zelgen Biopharmaceuticals Company Summary
Table 9. Suzhou Zelgen Biopharmaceuticals Deuterated Drugs Product Offerings
Table 10. Concert Pharmaceuticals Company Summary
Table 11. Concert Pharmaceuticals Deuterated Drugs Product Offerings
Table 12. Vertex Pharmaceuticals Company Summary
Table 13. Vertex Pharmaceuticals Deuterated Drugs Product Offerings
Table 14. Hinova Pharma Company Summary
Table 15. Hinova Pharma Deuterated Drugs Product Offerings
Table 16. Otsuka Pharmaceutical (Avanir) Company Summary
Table 17. Otsuka Pharmaceutical (Avanir) Deuterated Drugs Product Offerings
Table 18. Poxel SA (DeuteRx) Company Summary
Table 19. Poxel SA (DeuteRx) Deuterated Drugs Product Offerings
Table 20. By Region? Global Deuterated Drugs Revenue, (US$, Mn), 2024 & 2030
Table 21. By Region - Global Deuterated Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Type ? Global Deuterated Drugs Market Size, (US$, Mn), 2024 & 2030
Table 23. By Application? Global Deuterated Drugs Market Size, (US$, Mn), 2024 & 2030
List of Figures
Figure 1. Deuterated Drugs Segment by Type in 2030
Figure 2. Deuterated Drugs Segment by Application in 2030
Figure 3. Global Deuterated Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Deuterated Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Deuterated Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global Deuterated Drugs Revenue Market Share, 2024-2030
Figure 8. By Type - Global Deuterated Drugs Revenue Market Share, 2024-2030
Figure 9. By Application - Global Deuterated Drugs Revenue Market Share, 2024-2030
